Company: APXT
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001213900-25-097069
Chunk: 172

Company: Apex Treasury Corp
Filing Date: 2025-10-07
Form: S-1/A
Chunk 172
---
 |     | $           | 251,306,226 |   |

____________ (1)Represents the value of 45 -dayover -allotmentoption from the date of this offering granted to the underwriters to purchase an aggregate of up to 3,750,000 additional units at the initial public offering price less the underwriting discounts and commissions. We evaluate financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re -valuedat each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non -currentbased on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The underwriters’ over -allotmentoption is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of this offering. The value is derived through a Black -Scholesmodel estimating the closing stock price on grate date, assuming its June 30, 2025, volatility based on current market data of other SPAC entities of 3.86%, and the daily treasury yield curve as of the estimated close date, assuming June 30, 2025, of 4.41%. (2)Our sponsor may loan us up to $300,000 under an unsecured promissory note to be used for a portion of the expenses of this offering. The “as adjusted” information gives effect to the repayment of any loans received from our sponsor out of the proceeds from this offering and the sale of the private placement warrants. As of June 30, 2025, we had borrowed $12,420 under the promissory note with our sponsor. (3)In connection with the completion of our initial business combination, we will provide our public shareholders with the opportunity to redeem their public shares, regardless of whether they abstain, vote for, or against, our initial business combination, for cash at a per share price equal to the aggregate amount